209 related articles for article (PubMed ID: 29474680)
1. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1.
Chen J; Calhoun VD; Lin D; Perrone-Bizzozero NI; Bustillo JR; Pearlson GD; Potkin SG; van Erp TGM; Macciardi F; Ehrlich S; Ho BC; Sponheim SR; Wang L; Stephen JM; Mayer AR; Hanlon FM; Jung RE; Clementz BA; Keshavan MS; Gershon ES; Sweeney JA; Tamminga CA; Andreassen OA; Agartz I; Westlye LT; Sui J; Du Y; Turner JA; Liu J
Schizophr Bull; 2019 Jan; 45(1):222-232. PubMed ID: 29474680
[TBL] [Abstract][Full Text] [Related]
2. White matter correlates of episodic memory encoding and retrieval in schizophrenia.
Green AE; Croft RJ; Maller JJ; Fitzgerald PB
Psychiatry Res Neuroimaging; 2016 Aug; 254():188-98. PubMed ID: 27479923
[TBL] [Abstract][Full Text] [Related]
3. Guided exploration of genomic risk for gray matter abnormalities in schizophrenia using parallel independent component analysis with reference.
Chen J; Calhoun VD; Pearlson GD; Perrone-Bizzozero N; Sui J; Turner JA; Bustillo JR; Ehrlich S; Sponheim SR; Cañive JM; Ho BC; Liu J
Neuroimage; 2013 Dec; 83():384-96. PubMed ID: 23727316
[TBL] [Abstract][Full Text] [Related]
4. Cross-Tissue Exploration of Genetic and Epigenetic Effects on Brain Gray Matter in Schizophrenia.
Lin D; Chen J; Ehrlich S; Bustillo JR; Perrone-Bizzozero N; Walton E; Clark VP; Wang YP; Sui J; Du Y; Ho BC; Schulz CS; Calhoun VD; Liu J
Schizophr Bull; 2018 Feb; 44(2):443-452. PubMed ID: 28521044
[TBL] [Abstract][Full Text] [Related]
5. Common variation in ZNF804A (rs1344706) is not associated with brain morphometry in schizophrenia or healthy participants.
Quidé Y; Matosin N; Atkins JR; Fitzsimmons C; Cairns MJ; Carr VJ; ; Green MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():12-20. PubMed ID: 29247760
[TBL] [Abstract][Full Text] [Related]
6. Psychopathological Syndromes Across Affective and Psychotic Disorders Correlate With Gray Matter Volumes.
Stein F; Meller T; Brosch K; Schmitt S; Ringwald K; Pfarr JK; Meinert S; Thiel K; Lemke H; Waltemate L; Grotegerd D; Opel N; Jansen A; Nenadić I; Dannlowski U; Krug A; Kircher T
Schizophr Bull; 2021 Oct; 47(6):1740-1750. PubMed ID: 33860786
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.
Zhao C; Zhu J; Liu X; Pu C; Lai Y; Chen L; Yu X; Hong N
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():27-32. PubMed ID: 29292241
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
[TBL] [Abstract][Full Text] [Related]
9. Progressive post-onset reorganisation of MRI-derived cortical thickness in adolescents with schizophrenia.
Palaniyappan L; Das TK; Winmill L; Hough M; James A
Schizophr Res; 2019 Jun; 208():477-478. PubMed ID: 30722946
[No Abstract] [Full Text] [Related]
10. Sparse deep neural networks on imaging genetics for schizophrenia case-control classification.
Chen J; Li X; Calhoun VD; Turner JA; van Erp TGM; Wang L; Andreassen OA; Agartz I; Westlye LT; Jönsson E; Ford JM; Mathalon DH; Macciardi F; O'Leary DS; Liu J; Ji S
Hum Brain Mapp; 2021 Jun; 42(8):2556-2568. PubMed ID: 33724588
[TBL] [Abstract][Full Text] [Related]
11. ZNF804A variants confer risk for heroin addiction and affect decision making and gray matter volume in heroin abusers.
Sun Y; Zhao LY; Wang GB; Yue WH; He Y; Shu N; Lin QX; Wang F; Li JL; Chen N; Wang HM; Kosten TR; Feng JJ; Wang J; Tang YD; Liu SX; Deng GF; Diao GH; Tan YL; Han HB; Lin L; Shi J
Addict Biol; 2016 May; 21(3):657-66. PubMed ID: 25708696
[TBL] [Abstract][Full Text] [Related]
12. Distinct Associations of Cognitive Impairments and Reduced Gray Matter Volumes in Remitted Patients with Schizophrenia and Bipolar Disorder.
Sun T; Zhao P; Jiang X; Zhou Y; Li C; Jia L; Tang Y
Neural Plast; 2020; 2020():8859388. PubMed ID: 33381163
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia risk variants modulate white matter volume across the psychosis spectrum: evidence from two independent cohorts.
Oertel-Knöchel V; Lancaster TM; Knöchel C; Stäblein M; Storchak H; Reinke B; Jurcoane A; Kniep J; Prvulovic D; Mantripragada K; Tansey KE; O'Donovan MC; Owen MJ; Linden DE
Neuroimage Clin; 2015; 7():764-70. PubMed ID: 25844328
[TBL] [Abstract][Full Text] [Related]
14. The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia.
DeRosse P; Lencz T; Burdick KE; Siris SG; Kane JM; Malhotra AK
Schizophr Bull; 2008 Nov; 34(6):1047-53. PubMed ID: 18628273
[TBL] [Abstract][Full Text] [Related]
15. Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis.
Chang M; Womer FY; Bai C; Zhou Q; Wei S; Jiang X; Geng H; Zhou Y; Tang Y; Wang F
PLoS One; 2016; 11(10):e0163749. PubMed ID: 27723806
[TBL] [Abstract][Full Text] [Related]
16. Evidence of allelic imbalance in the schizophrenia susceptibility gene ZNF804A in human dorsolateral prefrontal cortex.
Guella I; Sequeira A; Rollins B; Morgan L; Myers RM; Watson SJ; Akil H; Bunney WE; Delisi LE; Byerley W; Vawter MP
Schizophr Res; 2014 Jan; 152(1):111-6. PubMed ID: 24315717
[TBL] [Abstract][Full Text] [Related]
17. Morphological changes in gray matter volume correlate with catechol-O-methyl transferase gene Val158Met polymorphism in first-episode treatment-naïve patients with schizophrenia.
Li ML; Xiang B; Li YF; Hu X; Wang Q; Guo WJ; Lei W; Huang CH; Zhao LS; Li N; Ren HY; Wang HY; Ma XH; Deng W; Li T
Neurosci Bull; 2015 Feb; 31(1):31-42. PubMed ID: 25564193
[TBL] [Abstract][Full Text] [Related]
18. Brain gray matter network organization in psychotic disorders.
Zhang W; Lei D; Keedy SK; Ivleva EI; Eum S; Yao L; Tamminga CA; Clementz BA; Keshavan MS; Pearlson GD; Gershon ES; Bishop JR; Gong Q; Lui S; Sweeney JA
Neuropsychopharmacology; 2020 Mar; 45(4):666-674. PubMed ID: 31812151
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of magnetic resonance imaging on the gray matter and resting-state function in prodromal and first-episode schizophrenia.
Lian N; Lv H; Guo W; Shen Y; Wu R; Liu Y; Zhu F; Hu M; Ou J; Zhao J
Am J Med Genet B Neuropsychiatr Genet; 2018 Sep; 177(6):537-545. PubMed ID: 30105860
[TBL] [Abstract][Full Text] [Related]
20. Influence of Psychotic Episodes on Grey Matter Volume Changes in Patients with Schizophrenia.
Ružić Baršić A; Rubeša G; Mance D; Miletić D; Gudelj L; Antulov R
Psychiatr Danub; 2020; 32(3-4):359-366. PubMed ID: 33370733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
